DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
P•••••••• C••••••••
Healthcare & Pharmaceuticalsgroup grade Aon a schedule nowsponsor unattributed
What matters now
- 100¢ → 95¢consensus mark
Consensus mark 95¢ on cost, down from 100¢ in Q3 2025, 92¢ last quarter.
Q2 2026 · The lenders' own valuations, the most direct read of what they expect to recover.
Derived2 of 2 lenders' own marks, weighted by principal
Mark path, consensus per quarter end
100¢ · 98¢ · 92¢ · 95¢Q3 2025 to Q2 2026
Where each lender marks it, 1 points apart
95¢96¢
Principal held
at least $10.9M
sum of BDC pieces, a lower bound
Fair value
$9.4M
95c on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
3
2 on the latest quarter
Facilities
1
0 equity pieces beside them
Next maturity
Apr 16, 2032
no dated debt inside 24 months
On the tape since
Sep 30, 2025
latest Jun 30, 2026
Events
2
dated, non-routine
Lender marks
each lender's own fair value over cost at Jun 30, 2026, folded to one row per lender
| Lender | Exposure | Current mark | QoQ change |
|---|---|---|---|
| A•••• P•••••• C••••• F•••• L•• | $9.93M | 95¢ | +4 pts |
| A•••• C••••• B•• I••• | $993K | 96¢ | +4 pts |
Every BDC piece · 2 positions across 2 lenderslargest principal first, with instrument and rate
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| A•••• P•••••• C••••• F•••• L•• | term loan first lien Investment T••• 1st L••• T••• L••• I•••• S+ S••••• 4.50% I••••••• R••• 8.23% A••••••••• D• | $9.9M | $8.5M 95c | SOFR+450 bp |
| A•••• C••••• B•• I••• | term loan first lien Investment T••• 1st L••• T••• L••• I•••• S+ S••••• 4.50% I••••••• R••• 8.23% A••••••••• D• | $992,500 | $854,796 96c | SOFR+450 bp |
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien | at least $10.9M | 95c | SOFR+450 bp | Apr 16, 2032 | 3 |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 2 | $10.9M | $9.4M | 95c | 0 |
| Mar 31, 2026 | 2 | $10.9M | $9.1M | 92c | 0 |
| Dec 31, 2025 | 3 | $22.5M | $19.9M | 98c | 0 |
| Sep 30, 2025 | 3 | $14.1M | $12.6M | 100c | 0 |
What changed
- Marked down across lendersMar 31, 2026
- Marked down (one lender)Mar 31, 2026
- Marked down (one lender)Mar 31, 2026
- Lender left a facilityDec 31, 2025
- New borrower on a BDC scheduleSep 30, 2025
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- P•••••••• C••••••••derivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 3 BDCsderived
- Industry
- Healthcare & Pharmaceuticalsreportedas one filer wrote it